Policy | February 02, 2024
Industry’s reaction to Union Budget 2024-25
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
The registered capital of the newly founded company is € 50 million
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
Collaboration streamlines patient access to oncology clinical trials
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
Subscribe To Our Newsletter & Stay Updated
